Tag: David Amess

The below Parliamentary question was asked by David Amess on 2015-10-30.

To ask the Secretary of State for Health, whether standard patient health assessments by GPs include assessing eye health.

Alistair Burt

The Government recognises that regular sight tests are an important measure in preventing avoidable sight loss.

Free National Health Service sight tests are available to many, including children, people aged 60 and over, people on benefits and those people at particular risk of developing eye disease.

We do not determine what should be included in health checks or consultation between general practitioners (GPs) and their patients. This is for GPs to decide, taking into account the individual needs of patients.

The below Parliamentary question was asked by David Amess on 2015-11-25.

To ask the Secretary of State for Health, what assessment he has made of the effectiveness of implementation of the NICE quality standards for rheumatoid arthritis.

Jane Ellison

Quality standards (QS) are important in setting out to patients, the public, commissioners and providers what a high quality service should look like in a particular area of care. Whilst providers and commissioners must have regard to the National Institute for Health and Care Excellence (NICE) QS in planning and delivering services, however they are not mandatory.

The QS for rheumatoid arthritis states that services should be commissioned from and coordinated across all relevant agencies encompassing the rheumatoid arthritis care pathway. A person-centred approach to provision of services is fundamental to delivering high-quality care to adults with rheumatoid arthritis. NHS England continues to champion their use with providers and commissioners.

NHS England is working with patients, the pharmaceutical industry, royal colleges and others to encourage a range of improvements aimed at ensuring that all patients, including those with inflammatory arthritis, get the support they need to get the most from their medicines. The development of the four principles to support medicines optimisation offers a step change to the way we think about medicine use in the NHS. The four guiding patient-centred principles: aim to understand the patient’s experience; evidence-based choice of medicines; make medicines optimisation part of routine practice; ensure medicines use is as safe as possible are applicable to all patients, conditions and disease states.

The medicines optimisation best practice guidance, published in May 2014 is available at:

www.rpharms.com/promoting-pharmacy-pdfs/helping-patients-make-the-most-of-their-medicines.pdf.

“

The below Parliamentary question was asked by David Amess on 2015-12-17.

To ask the Secretary of State for Health, how many people with hepatitis C have commenced treatment under the commissioning policy for the treatment of patients with cirrhosis since June 2015.

Jane Ellison

At 10 November 2015, NHS England had received 2,667 applications to treat from clinicians. Applications relate to patients who either meet NHS England’s commissioning policy for the treatment of hepatitis C patients with cirrhosis or who meet the NICE Technology Appraisal guidance for sofosbuvir and simeprevir. The number of applications is likely to be slightly higher than the number starting treatment, as some patients may have decided not to proceed. NHS England expects to have an automated system in place by April 2016 to collect data on treatment referrals and treatment history, including clinical outcome data.

The below Parliamentary question was asked by David Amess on 2016-01-29.

To ask Mr Chancellor of the Exchequer, how much revenue has accrued to the public purse from Fixed Odds Betting Terminals in each of the last three years; and if he will make a statement.

Damian Hinds

Total Machine Games Duty (MGD) receipts for the years ending 31 March 2015 and 2014 were £562 million and £502 million. Total Amusement Machine Licence Duty receipts for the year ending 31 March 2013 were £151million.

Receipts from fixed odds betting terminals are not separately identified in the figures published in HMRC’s Tax & Duty bulletin. The bulletin can be found here:

https://www.uktradeinfo.com/Statistics/Pages/TaxAndDutyBulletins.aspx

“

The below Parliamentary question was asked by David Amess on 2016-03-01.

To ask the Secretary of State for Health, what discussions his Department has had with NICE and NHS England on the availability of Erbitux for metastatic colorectal cancer patients.

George Freeman

I refer the hon. Member to the answer I gave on 24 February 2016 to Question 27585.

“

The below Parliamentary question was asked by David Amess on 2016-03-22.

To ask the Secretary of State for Health, whether he has taken steps to provide national guidance to ensure that healthcare and wider staff in prisons are given adequate levels of training around blood-borne viruses as recommended by The Hepatitis C Trust’s recent report, The blood-borne virus opt-out testing policy for prisons in England: An analysis of need towards full implementation, published on 3 March 2016.

Ben Gummer

Implementation of opt-out testing for blood-borne viruses (BBVs) in all adult prisons in England in a shared priority for Public Health England (PHE), NHS England and the National Offender Management Service as published in our second National Partnership Agreement for 2015-16.

To support implementation, PHE and its partners, including The Hepatitis C Trust among other third sector organisations, have developed a broad range of range of resources to support prison healthcare teams. These include information leaflets and posters, testing algorithms, web-based and DVD resources which cover all aspects of prevention, diagnosis and treatment of Hepatitis C and other BBVs to support prison healthcare teams in offering testing, managing both positive and negative results, providing advice on harm minimisation and supporting people into treatment.

The below Parliamentary question was asked by David Amess on 2016-07-11.

To ask the Secretary of State for Culture, Media and Sport, if Sport England will take steps to ensure that children’s fitness and activity levels do not decline from their term-time levels in the summer holidays.

Tracey Crouch

We want to ensure that all children, regardless of background, ability or where they live, are able to engage in sport and physical activity in a way that interests and benefits them. Through the Government’s sports strategy Sporting Future, published in December 2015, Sport England will now invest in sporting provision for children aged five and over – previously the starting age was 14 years old.

In addition, Sport England’s new strategy, Towards an Active Nation, published in May 2016, sets out their plans to make a major new investment of £40 million into projects which offer new opportunities for families with children to get active and play sport together. Sport England will continue to work with organisations across the sport sector as it implements its strategy.

The below Parliamentary question was asked by David Amess on 2015-10-30.

To ask the Secretary of State for Health, what estimate he has made of the number of people likely to have age-related macular degeneration in 2050.

Alistair Burt

The Department has made no estimate of the number of people likely to have age-related macular degeneration in 2050.

The below Parliamentary question was asked by David Amess on 2015-11-25.

To ask the Secretary of State for Health, what steps his Department is taking to ensure the medicines optimisation programme’s principle of ensuring that the right patient gets the right choice of medicine, at the right time, is applied to people with inflammatory arthritis.

Jane Ellison

Quality standards (QS) are important in setting out to patients, the public, commissioners and providers what a high quality service should look like in a particular area of care. Whilst providers and commissioners must have regard to the National Institute for Health and Care Excellence (NICE) QS in planning and delivering services, however they are not mandatory.

The QS for rheumatoid arthritis states that services should be commissioned from and coordinated across all relevant agencies encompassing the rheumatoid arthritis care pathway. A person-centred approach to provision of services is fundamental to delivering high-quality care to adults with rheumatoid arthritis. NHS England continues to champion their use with providers and commissioners.

NHS England is working with patients, the pharmaceutical industry, royal colleges and others to encourage a range of improvements aimed at ensuring that all patients, including those with inflammatory arthritis, get the support they need to get the most from their medicines. The development of the four principles to support medicines optimisation offers a step change to the way we think about medicine use in the NHS. The four guiding patient-centred principles: aim to understand the patient’s experience; evidence-based choice of medicines; make medicines optimisation part of routine practice; ensure medicines use is as safe as possible are applicable to all patients, conditions and disease states.

The medicines optimisation best practice guidance, published in May 2014 is available at:

www.rpharms.com/promoting-pharmacy-pdfs/helping-patients-make-the-most-of-their-medicines.pdf.

“

The below Parliamentary question was asked by David Amess on 2015-12-17.

To ask the Secretary of State for Health, whether the hepatitis C Improvement Framework will include provisions on clinical commissioning groups and local authorities to engage with the Operational Delivery Networks jointly to commission services.

Jane Ellison

The draft hepatitis C Improvement Framework has focused on public health improvements in hepatitis C. As such, this does not include provisions on clinical commissioning groups and local authorities to engage with Operational Delivery Networks to jointly commission services as this is beyond the governance remit of the work. In its 2014 report Hepatitis C in the UK, Public Health England recommended that “Health (and, in England, local authority) commissioners should work together to consider how to improve the availability, access and uptake of approved hepatitis C treatments in primary and secondary care, drug treatment services, prisons and other settings, and to drive innovative approaches to provide outreach”. In support of this, I hosted a summit on 3 March 2015 with local authority and voluntary sector representatives, public health and clinical experts to share best practice and explore actions that could be taken at local government level to significantly reduce the burden of hepatitis C and tuberculosis in England.